Pelthos Therapeutics PTHS
NYSE PTHS
$8.98 -0.39 (-4.16%)
As of: Nov 10, 2026 · 3:07 PM EST

Pelthos Therapeutics (PTHS) Net Long-Term Debt Issued (Repaid) (2023 - 2026)

Updated

Pelthos Therapeutics' Non-Current Debt was $243.00 in Q4 2024.

Analysis

Pelthos Therapeutics (PTHS) Net Long-Term Debt Issued (Repaid) (2023 - 2026) Analysis & Trends

For FY2024, Non-Current Debt at Pelthos Therapeutics came in at -$214,757.

  • In earlier years, Non-Current Debt was $300,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Pelthos Therapeutics 32.83 Mn -55.57 Mn 11.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 29.34 Mn
Dec 31, 2025 17.90 Mn
Sep 30, 2025 68,000.00
Jun 30, 2025 375,000.00
Mar 31, 2025 250,000.00
Dec 31, 2024 -154,000.00
Sep 30, 2024 -897,284.00
Dec 31, 2023 175,000.00
Sep 30, 2023 198,128.00
Jun 30, 2023 226,905.00
Mar 31, 2023 166,903.00
API Access

Pelthos Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PTHS&period=max&api_key=YOUR_API_KEY